Senior Vice President of Development Operations and Portfolio Management, PPD, Inc.
| Role | Organisation | Sources |
|---|---|---|
| Senior Vice President of Development Operations and Portfolio Management | PPD, Inc. | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Elisha Talley-Roithner. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Biotech firm ENA Respiratory has contracted PPD and hVIVO to run Phase 2 trials of its INNA-051 nasal spray, which aims to prevent COVID-19 and other respiratory viral infections, after encouraging Phase 1 safety results.
Biotech firm ENA Respiratory has contracted research organisations PPD and hVIVO to run Phase 2 trials of its INNA-051 nasal spray, following encouraging Phase 1 safety results, with participant recruitment expected from January 2022.